Form 4 for AXGN Axogen, Inc.
Accepted 2023-01-27 00:00:00 ET · period of report 2023-01-25 · accession 0000805928-23-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-27 | 2023-01-25+ | AXGN | MARIANI PETER J | EVP, CFO | S - Sale+OE | $10.10 | -62.8K | 42.1K | -60% | -$634.3K |
| DM | 2023-01-27 | 2023-01-25+ | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $5.04 | +62.8K | 63.0K | +27,431% | +$316.6K |
| DM | 2023-01-27 | 2023-01-25+ | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $0.00 | -62.8K | 104.7K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-25 | S | D | 20,939 | $10.23 | 42,108 | D | — | — | (F2) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.05 to $10.76 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-01-26 | M | A | 20,939 | $5.04 | 63,047 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-26 | S | D | 20,939 | $9.90 | 42,108 | D | — | — | (F3) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.61 to $10.28 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2023-01-27 | M | A | 20,940 | $5.04 | 63,048 | D | — | — | |
| 5 | Common | Common Stock | 2023-01-27 | S | D | 20,940 | $10.16 | 42,108 | D | — | — | (F4) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.70 to $10.34 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2023-01-25 | M | A | 20,939 | $5.04 | 63,047 | D | — | — | |
| 7 | Derivative | Employee Stock Option (right to purchase) | 2023-01-27 | M | D | 20,940 | $0.00 | 62,818 | D | $5.04 · 2020-03-01 to 2023-03-01 | 20,940 Common Stock | (F5) All shares of Common Stock underlying the employee stock option were fully vested on March 1, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 1, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. |
| 8 | Derivative | Employee Stock Option (right to purchase) | 2023-01-26 | M | D | 20,939 | $0.00 | 83,758 | D | $5.04 · 2020-03-01 to 2023-03-01 | 20,939 Common Stock | (F5) All shares of Common Stock underlying the employee stock option were fully vested on March 1, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 1, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. |
| 9 | Derivative | Employee Stock Option (right to purchase) | 2023-01-25 | M | D | 20,939 | $0.00 | 104,697 | D | $5.04 · 2020-03-01 to 2023-03-01 | 20,939 Common Stock | (F5) All shares of Common Stock underlying the employee stock option were fully vested on March 1, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 1, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. |